Skin ulcer (SU) may increase the risk of systemic infections and have evolved into an important public health problem. However, there is a lack of research specifically on drug-induced SU. We extracte

Taylor & Francis Group2025-05-14 更新40

Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews

药物警戒

住院患者安全

Background Preventable adverse drug reactions (PADRs) in inpatients are associated with harm, including increased length of stay and potential loss of life, and result in elevated costs of care. We co

NIAID Data Ecosystem20

Updated insights on levetiracetam-associated severe cutaneous adverse reactions: a real-world pharmacovigilance analysis

药物警戒

皮肤不良反应

Previous studies have explored the association between levetiracetam (LEV) and severe cutaneous adverse reactions (SCARs). However, most investigations have relied on clinical trial data or case repor

DataCite Commons2025-05-14 更新40

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

药物警戒

药物不良反应监测

Gemcitabine is widely used in the treatment of various cancers. This study aims to evaluate gemcitabine-associated adverse events (AEs) using the Food and Drug Administration Adverse Event Reporting S

Taylor & Francis Group2025-03-13 更新40

Characteristics of reports associated with venetoclax from 2016 Q2 to 2021.

资源简介：

相关数据集